Small kinase assay panels can provide a measure of selectivity.

In this Letter, a novel strategy for assessment of ligand promiscuity is described. By using a carefully selected small set of kinases together with multivariate statistical methods, a measure of selectivity can be estimated. This will facilitate an appropriate selection of compounds for further development in lead generation and optimization.

[1]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[2]  R. Horuk,et al.  Promiscuous drugs as therapeutics for chemokine receptors , 2009, Expert Reviews in Molecular Medicine.

[3]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[4]  S. Knapp,et al.  A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases , 2007, Proceedings of the National Academy of Sciences.

[5]  Tranter.  Preparing for the new millennium. , 1999, Drug discovery today.

[6]  Elizabeth A. Lunney,et al.  Prediction of specificity-determining residues for small-molecule kinase inhibitors , 2008, BMC Bioinformatics.

[7]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.

[8]  P. Graczyk.  Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases. , 2007, Journal of medicinal chemistry.

[9]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[10]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[11]  Hualin Xi,et al.  Predicting Kinase Selectivity Profiles Using Free-Wilson QSAR Analysis , 2008, J. Chem. Inf. Model..

[12]  S. Deacon,et al.  The challenge of selecting protein kinase assays for lead discovery optimization , 2008, Expert opinion on drug discovery.

[13]  Gavin Harper,et al.  Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. , 2008, Journal of medicinal chemistry.

[14]  S. Hanks,et al.  Genomic analysis of the eukaryotic protein kinase superfamily: a perspective , 2003, Genome Biology.

[15]  P. Cohen.  Protein kinases — the major drug targets of the twenty-first century? , 2002, Nature reviews. Drug discovery.

[16]  M. Sawa.  Strategies for the design of selective protein kinase inhibitors. , 2008, Mini reviews in medicinal chemistry.

[17]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .